26s protease
Recently Published Documents


TOTAL DOCUMENTS

18
(FIVE YEARS 2)

H-INDEX

10
(FIVE YEARS 1)

Biomolecules ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. 150 ◽  
Author(s):  
de Araujo ◽  
Heimann ◽  
Remer ◽  
Russo ◽  
Colquhoun ◽  
...  

Intracellular peptides are produced by proteasomes following degradation of nuclear, cytosolic, and mitochondrial proteins, and can be further processed by additional peptidases generating a larger pool of peptides within cells. Thousands of intracellular peptides have been sequenced in plants, yeast, zebrafish, rodents, and in human cells and tissues. Relative levels of intracellular peptides undergo changes in human diseases and also when cells are stimulated, corroborating their biological function. However, only a few intracellular peptides have been pharmacologically characterized and their biological significance and mechanism of action remains elusive. Here, some historical and general aspects on intracellular peptides’ biology and pharmacology are presented. Hemopressin and Pep19 are examples of intracellular peptides pharmacologically characterized as inverse agonists to cannabinoid type 1 G-protein coupled receptors (CB1R), and hemopressin fragment NFKF is shown herein to attenuate the symptoms of pilocarpine-induced epileptic seizures. Intracellular peptides EL28 (derived from proteasome 26S protease regulatory subunit 4; Rpt2), PepH (derived from Histone H2B type 1-H), and Pep5 (derived from G1/S-specific cyclin D2) are examples of peptides that function intracellularly. Intracellular peptides are suggested as biological functional molecules, and are also promising prototypes for new drug development.


PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e36142 ◽  
Author(s):  
Wei Bi ◽  
Xiuna Jing ◽  
Lihong Zhu ◽  
Yanran Liang ◽  
Jun Liu ◽  
...  

1999 ◽  
Vol 277 (2) ◽  
pp. R434-R440 ◽  
Author(s):  
Scott C. Hobler ◽  
Arthur Williams ◽  
David Fischer ◽  
Jing Jing Wang ◽  
Xiaoyan Sun ◽  
...  

Recent studies suggest that sepsis stimulates ubiquitin-dependent protein breakdown in skeletal muscle. In this proteolytic pathway, ubiquitinated proteins are recognized, unfolded, and degraded by the multicatalytic 26S protease complex. The 20S proteasome is the catalytic core of the 26S protease complex. The role of the 20S proteasome in the regulation of sepsis-induced muscle proteolysis is not known. We tested the hypothesis that sepsis increases 20S proteasome activity and the expression of mRNA for various subunits of this complex. Proteolytic activity of isolated 20S proteasomes, assessed as activity against fluorogenic peptide substrates, was increased in extensor digitorum longus muscles from septic rats. The proteolytic activity was inhibited by specific proteasome blockers. Northern blot analysis revealed an approximately twofold increase in the relative abundance of mRNA for the 20S α-subunits RC3 and RC9 and the β-subunit RC7. However, Western blot analysis did not show any difference in RC9 protein content between sham-operated and septic rats. The increased activity and expression of the 20S proteasome in muscles from septic rats lend further support for a role of the ubiquitin-proteasome-pathway in the regulation of sepsis-induced muscle proteolysis.


1999 ◽  
Vol 77 (3) ◽  
pp. 223-228 ◽  
Author(s):  
Kayoko Tateishi ◽  
Yoshio Misumi ◽  
Yukio Ikehara ◽  
Kyoko Miyasaka ◽  
Akihiro Funakoshi

Antisecretory factor (AF) was identified as a pituitary protein that inhibits the intestinal fluid secretion induced by cholera toxin. One aim of this study was to elucidate whether AF is also synthesized in the intestine or if AF produced in the pituitary is transported to the intestinal tract for its function there. cDNA clones encoding a protein proposed to be AF were isolated from rat pituitary gland and intestinal mucosa cDNA libraries. The nucleotide sequences of clones isolated from the rat pituitary gland and intestinal mucosa were identical. The deduced amino acid sequence was highly homologous to the sequence for subunit 5a of the human 26S protease that exists abundantly in the cytosol and nucleus. The production of AF in the intestine was confirmed by Northern blot and immunoblot analyses. Immunocytochemical observations of cells transfected with the rat AF cDNA showed that the AF protein was localized in the cytoplasm. These findings suggest that the protein proposed to be AF may be a cytoplasmic protein, it exists in the intestine rather than being transported from the pituitary gland, and it may function in intestinal cells.Key words: rat antisecretory factor, 26S protease, S5a, cytoplasmic protein.


1996 ◽  
Vol 7 (3) ◽  
pp. 180-185 ◽  
Author(s):  
T. Leeb ◽  
G. Rettenberger ◽  
J. Bruch ◽  
H. Hameister ◽  
B. Brenig

FEBS Letters ◽  
1996 ◽  
Vol 381 (1-2) ◽  
pp. 143-148 ◽  
Author(s):  
Katherine Ferrell ◽  
Quinn Deveraux ◽  
Steven van Nocker ◽  
Martin Rechsteiner

Sign in / Sign up

Export Citation Format

Share Document